Compare TENB & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TENB | INSP |
|---|---|---|
| Founded | 2002 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | 2018 | 2018 |
| Metric | TENB | INSP |
|---|---|---|
| Price | $26.48 | $139.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | $39.25 | ★ $130.79 |
| AVG Volume (30 Days) | 1.1M | ★ 1.6M |
| Earning Date | 10-29-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | N/A | ★ 1.48 |
| Revenue | ★ $974,603,000.00 | $882,622,000.00 |
| Revenue This Year | $12.22 | $14.83 |
| Revenue Next Year | $7.62 | $14.44 |
| P/E Ratio | ★ N/A | $85.59 |
| Revenue Growth | 11.05 | ★ 16.81 |
| 52 Week Low | $25.28 | $70.77 |
| 52 Week High | $45.45 | $216.01 |
| Indicator | TENB | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 81.40 |
| Support Level | $26.18 | $124.16 |
| Resistance Level | $26.65 | $138.80 |
| Average True Range (ATR) | 0.68 | 6.46 |
| MACD | 0.08 | 5.10 |
| Stochastic Oscillator | 37.62 | 97.84 |
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.